Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review)

Oncology Letters

Volumn 1, Issue 6, 2010, Pages 941-945

  Ricci, Sante Basso ^a   Cerchiari, Ugo ^a  

^a IRCCS   (Italy)

Author keywords

Dialytic membrane; Immune system; Malignant tumors; Spontaneous regression

Indexed keywords

METALLOPROTEINASE;

CANCER CELL; CANCER INHIBITION; CANCER REGRESSION; CELL PROLIFERATION; CORRELATION COEFFICIENT; DIALYSIS MEMBRANE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; KIDNEY CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; REMISSION; REVIEW; TUMOR IMMUNOLOGY;

EID: 77957946430     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2010.176     Document Type: Review

References (31)

1. Chen Y, Takita J, Choi YL, et al: Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455: 971-974, 2008.
2. Aoyama M, Ozaki T, Inuzuka H, et al: LMO3 interacts with neuronal transcription factor HEN2 and acts as an oncogene in neuroblastoma. Cancer Res 65: 4587-4597, 2005.
3. Munirajan AK, Ando K, Mukai A, et al: KIF1B(beta) functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem 283: 24426-24434, 2008.
4. Huang TW, Chen YL, Chen JC, Tsai WC, Chang H and Lee SC: Spontaneous regression of a mediastinal thymoma. J Thorac Cardiovasc Surg 137: 1277-1278, 2009.
5. Balzer BL and Ulbright TM: Spontaneous regression of testicular germ cell tumors. An analysis of 42 cases. Am J Surg Pathol 30: 858-865, 2006.
6. Printz C: Spontaneous regression of melanoma may offer insight into cancer immunology. J Natl Cancer Inst 93: 1047-1048, 2001.
7. Li AJ, Wu MC, Cong WM, Shen F and Yi B: Spontaneous complete necrosis of hepatocellular carcinoma: a case report. Hepatobiliary Pancreat Dis Int 2: 152-154, 2003.
8. Basso Ricci S, Coradini D, Di Fronzo G, Bartoli C and Villa S: Estrogen receptor status of patients subjected to mastectomy for breast cancer with a disease-free interval of no less than 8 years. Am J Clin Oncol 21: 250-252, 1998.
9. Basso Ricci S: Letter to the editor. Med Hypothesis 64: 428-431, 2005.
10. Reed JC: Balancing cell life and death. Bax, apoptosis, and breast cancer. J Clin Invest 97: 2403-2404, 1996.
11. Teixeira C, Reed JC and Pratt MAC: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902-3912, 1995.
12. Wang TTY and Phang JM: Effects of estrogen on apoptosis pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489, 1995.
13. nd edition. Vol. 1. Bland K and Copeland EM III (eds). WB Saunders, Philadelphia, p518, 1998.
14. Lederman GS, Niloff JM, Redline R and Rosen EM: Late recurrence in endometrial carcinoma. Cancer 59: 825-828, 1987.
15. Tubiana N, Schlumberger M, Rougier P, et al: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55: 794-804, 1985.
16. Van den Ouden D, Hop WC and Schröder FH: Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy. J Urol 160: 1392-1397, 1998.
17. Wang XW: Role of p53 and apoptosis in carcinogenesis. Anticancer Res 19: 4759-4771, 1999.
18. Navratil JS, Liu CC and Ahearn JM: Apoptosis and autoimmunity. Immunol Res 36: 3-12, 2006.
19. Yamashita Y, Kumabe T, Shimizu H, Ezura Hand Tominaga T: Spontaneous regression of a primary cerebral tumor following vasospasm caused by subarachnoid hemorrhage due to rupture of an intracranial aneurism. A case report. Neurol Med Chir 4: 187-190, 2004.
20. Wu J and Lanier LL: Natural killer cells and cancer. Adv Cancer Res 90: 127-156, 2003.
21. Lanier LL, Corliss BC, Wu J, Leong C and Phillips JH: Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707, 1998.
22. Lanier LL, Yu G and Phillips JH: Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 142: 803-805, 1989.
23. Brooks AG, Posch PE, Scorzelli CT, Borrego F and Coligan JE: NKG2A complexed with CD94 defines a novel inhibitory natural kill cell receptor. J Exp Med 185: 795-800, 1997.
24. Lanier LL: Natural killer cell receptor signaling. Curr Opin Immunol 15: 308-314, 2003.
25. Munshi HG and Stack MS: Reciprocal interaction between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25: 45-56, 2006.
26. Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Natl Rev Cancer 2: 91-100, 2002.
27. Hoskin DH, Mader JS, Furlong SJ, Conrad DM and Blay J: Inhibition of T-cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int J Oncol 18: 527-535, 2008.
28. Kurita M, Hirano K, Ebihara S, et al: Spontaneous regression of cervical lymph node metastasis in patients with mesopharyngeal squamous cell carcinoma of the tongue: possible association between apoptosis and tumor regression. Int J Clin Oncol 12: 448-454, 2007.
29. Thoroddsen A, Geirsson G, Agnarsson BA and Magnusson K: Spontaneous regression of pleural metastases after nephrectomy for renal cell carcinoma. Scand J Urol Nephrol 5: 396-398, 2002.
30. DeWeerd JH, Hawthorne J and Adson MA: Regression of renal cell hepatic metastases following removal of primary lesions. JUrol 117: 790-792, 1977.
31. Basso Ricci S: Dialysis membrane and metastatic cancer cells. Clin Nephrol 68: 354-356, 2007.